Abstract
Hepatocellular carcinoma (HCC) is one of the major malignancies associated with high mortality rates. Chinese herbal medicine (CHM) alone, or in combination with conventional therapies (CT), has been widely used for patients with HCC in China. This study aims to explore how integrative therapy (IT) through the combination of CHM and CT affects the survival of patients with intermediate-advanced HCC. A retrospective cohort study was performed at the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. Data of consecutive patients diagnosed with intermediate-advanced HCC and a specific traditional Chinese medicine diagnostic pattern between January 2006 and December 2013 were retrieved from the electronic medical record system at the hospital. Patients were divided into 3 groups based on the therapies used, that is, IT, CHM alone, and CT alone, and the survival times of these patients was compared. A total of 328 patients were included in this study. Median follow-up period was 26.4 months (95% confidence interval [CI] = 22.7-38.9). Median overall survival was 11.0 months for IT, 8.6 months for CHM, and 9.4 months for CT groups ( P < .001). The adjusted hazard ratio (HR) of death for the IT gro...Continue Reading
References
Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
Jan 6, 1999·Controlled Clinical Trials·W D Dupont, W D Plummer
Feb 24, 2001·Journal of Gastroenterology and Hepatology·I MericanD Z Xu
Jun 7, 2002·Lancet·Josep M LlovetUNKNOWN Barcelona Liver Cancer Group
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Sep 14, 2006·European Journal of Cancer Care·W XuJ-P Collet
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Feb 12, 2009·Journal of Gastroenterology and Hepatology·Kang Mo KimDong Jin Suh
Feb 20, 2010·Molecular Nutrition & Food Research·Chi-Cheng LuJing-Gung Chung
Mar 11, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Edoardo G GianniniUNKNOWN Italian Liver Cancer group
Jan 25, 2011·Chinese Medicine·Ding-Fung TohHwee-Ling Koh
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Apr 21, 2012·Cancer·Joanne ChiuThomas Yau
May 9, 2012·Phytotherapy Research : PTR·Jian-Qing YuJia-Chuan Lei
Oct 25, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Jennifer L McQuadeLorenzo Cohen
Aug 21, 2013·Vaccine·Xiaofeng LiangYu Wang
Sep 21, 2013·Digestive Diseases and Sciences·O Abdel-Rahman, Z A Elsayed
Apr 3, 2014·Journal of Food Science·Shidong KanJi'an Li
Aug 2, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Chong ZhongRong-Ping Guo
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Apr 16, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Yueh-Hsiang LiaoTsai-Chung Li
Mar 19, 2016·Journal of Surgical Oncology·Xuesong YaoHuai Li
Aug 19, 2016·Drug Design, Development and Therapy·Cheng Wu TangYin Yuan Zheng
Apr 15, 2017·Oncotarget·Jian-Hong ZhongLe-Qun Li
Jul 1, 2017·Scientific Reports·Zhaofeng ShiLei Shang
Jul 7, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Zongguo YangYongchun Yu
Citations
Jan 19, 2019·Oncology Letters·Changshuang FuJinyao Li
May 10, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Zhulin WuLisheng Peng
Oct 8, 2020·Medicinal Research Reviews·Jianqing YuPaul B S Lai
Sep 5, 2020·Genes & Diseases·Xia LiaoQingan Jia
May 28, 2019·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·XiaoLi LiuZhiYun Yang
Mar 13, 2021·Complementary Therapies in Clinical Practice·Xizhu XuYang Deng
Apr 6, 2021·Frontiers in Pharmacology·Yiwen LiLuqi Huang